Sign Up to like & get
recommendations!
0
Published in 2017 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2017.00310
Abstract: Background Before implementation in clinical practice, biomarker assays need to be thoroughly analytically validated. There is currently a strong interest in implementation of the ratio of amyloid-β peptide 1-42 and 1-40 (Aβ42/Aβ40) in clinical routine.…
read more here.
Keywords:
multicenter analytical;
analytical validation;
validation;
implementation ... See more keywords